Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Completed · Not applicable
Conditions studied: Bloodstream Infections, Short Bowel Syndrome, Development, Nutrition, Biological Markers
In brief
The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
Key facts
- Study ID
- NCT01576003
- Run by
- Children's Hospital Medical Center, Cincinnati
- People needed
- 10
- Starts
- 2012-04-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2020-06-11
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: accepted.
Where it is running
- C.S. Mott Children's Hosptial — Ann Arbor, Michigan, United States
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.